Related Experiment Videos
[A comparative study of serum complement (C3 and C4) in inflammatory joint diseases]
Summary
Complement fractions C3 and C4 are elevated in inflammatory joint diseases, correlating with other acute phase reactants. These findings suggest C3 and C4 can serve as valuable acute phase indices for diagnosing and monitoring arthritis conditions.
Area of Science:
- Immunology
- Rheumatology
- Clinical Chemistry
Background:
- Inflammatory joint diseases involve complex immune responses.
- Acute phase reactants are crucial biomarkers for inflammation.
- The role of complement fractions in various arthritic conditions requires further elucidation.
Purpose of the Study:
- To investigate the levels of complement fractions (C3 and C4) and other acute phase reactants in patients with diverse inflammatory joint diseases.
- To assess the correlation between complement fractions and established acute phase indices.
- To determine the potential utility of C3 and C4 as acute phase reactants in rheumatology.
Main Methods:
- Quantitative analysis of complement fractions (C3, C4), haptoglobin, fibrinogen, alpha 1-glycoprotein, alpha 2-macroglobulin, and transferrin.
- Study population included 692 patients with various inflammatory joint diseases and 60 healthy controls.
- Comparison of marker levels in active and non-active disease phases.
Main Results:
- Elevated levels of complement fractions C3 and C4 were observed across most patient groups and disease phases.
- Significant positive correlations were found between C3, C4, and other acute phase indices.
- A clear hierarchy of acute phase reactivity was established, with fibrinogen and haptoglobin being the most reactive, followed by alpha 1-glycoprotein, C3, C4, alpha 2-macroglobulin, and transferrin.
Conclusions:
- Complement fractions C3 and C4 demonstrate significant elevations in inflammatory joint diseases.
- C3 and C4 exhibit strong correlations with other established acute phase reactants.
- C3 and C4 can be considered valuable additions to the panel of acute phase reacting indices for assessing inflammatory arthritis.